Filtered By:
Specialty: Cardiology
Condition: Diabetes Mellitus
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 1202 results found since Jan 2013.
Atherosclerotic patients with diabetes mellitus may break through the threshold of healthy TMAO levels formed by long-term statins therapy
CONCLUSION: Diabetics have abnormally high plasma TMAO levels even under continuous statins treatment, which may contribute to the development and progression of atherosclerosis. Therefore, it is necessary to focus on monitoring TMAO levels in diabetic patients to reduce adverse cardiovascular events in diabetic patients.PMID:36879744 | PMC:PMC9984437 | DOI:10.1016/j.heliyon.2023.e13657
Source: Atherosclerosis - March 7, 2023 Category: Cardiology Authors: Hao Liang Anqi Yu Zheng Wang Na Zhang Qingsong Wang Haichao Gao Junhui Gao Xinjun Wang Hong Wang Source Type: research
Association between carotid intima media thickness and acute ischemic stroke at an Indonesian tertiary referral hospital
CONCLUSIONS: AIS was associated with atherosclerosis, on the basis of CIMT measurements, according to age, BMI, sex, T2DM, hypertension, smoking status, dyslipidemia, socioeconomic status, and education level in the Indonesian population.PMID:36852246 | PMC:PMC9957772 | DOI:10.1016/j.jtumed.2022.12.008
Source: Atherosclerosis - February 28, 2023 Category: Cardiology Authors: Rivan Danuaji Suroto Suroto Bambang Purwanto Dono Indarto Faizal Muhammad Diah K Mirawati Vitri Widyaningsih Soetrisno Soetrisno Subandi Subandi Pepi Budianto Yetty Hambarsari Baarid L Hamidi Hanindia R Prabaningtyas Ervina A J Hutabarat Ira Ristinawati T Source Type: research
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
CONCLUSION: S-CSF2-Ab was useful for the diagnosis of atherosclerosis-related AIS, AMI, DM, and CKD and could discriminate poor prognosis, especially in p53-Ab-negative CRC.PMID:36844744 | PMC:PMC9954151 | DOI:10.3389/fcvm.2023.1042272
Source: Atherosclerosis - February 27, 2023 Category: Cardiology Authors: Shu-Yang Li Yoichi Yoshida Masaaki Kubota Bo-Shi Zhang Tomoo Matsutani Masaaki Ito Satoshi Yajima Kimihiko Yoshida Seiichiro Mine Toshio Machida Aiko Hayashi Minoru Takemoto Koutaro Yokote Mikiko Ohno Eiichiro Nishi Kenichiro Kitamura Ikuo Kamitsukasa Hir Source Type: research
Role of plaque inflammation in symptomatic carotid stenosis
CONCLUSION: Plaque inflammation as quantified on FDG-PET may serve as a reliable biomarker for risk stratification among patients with ECAD and recent TIA or ischemic stroke. Future studies should evaluate whether patients with significant plaque inflammation as quantified on FDG-PET benefit from carotid revascularization and/or anti-inflammatory therapy.PMID:36761341 | PMC:PMC9902904 | DOI:10.3389/fneur.2023.1086465
Source: Atherosclerosis - February 10, 2023 Category: Cardiology Authors: Yilong Zheng Mervyn Jun Rui Lim Benjamin Yong-Qiang Tan Bernard Poon Lap Chan Prakash Paliwal Ong Jia Yuan Jonathan Chandra Bharatendu Amanda Chee Yun Chan Leonard Leong Litt Yeo Joy Vijayan Chiew S Hong Young Heng Chee Lily Y H Wong Jintao Chen Victor Ya Source Type: research
Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry
AbstractEvidence suggests that atrial fibrillation (AF) could increase the risk of worsening kidney function (WKF) which is linked to an increased risk of stroke, bleeding, and death in AF patients. However, limited data exist regarding the factors that could lead to WKF in these patients. Therefore, we sought to identify the potential factors associated with the development of WKF in patients with non-valvular AF (NVAF). We analyzed prospectively recruited 1122 NVAF patients [men 71.9%, median age 73.0 years (interquartile range: 66.0–79.0)] with a baseline estimated glomerular filtration rate (eGFR) ≥ 15 mL/mi...
Source: Heart and Vessels - February 6, 2023 Category: Cardiology Source Type: research
Long-term risk, clinical management, and healthcare resource utilization of stable patients with coronary artery disease and post-myocardial infarction in Greece-TIGREECE study
CONCLUSIONS: Study results indicate that in the routine care of Greece one in ten patients experience a recurring CV event or death, mainly of ischemic origin, 1-3 years post-MI.PMID:36746373 | DOI:10.1016/j.hjc.2023.01.007
Source: Hellenic Journal of Cardiology - February 6, 2023 Category: Cardiology Authors: Filippos Anastasiadis Dimitrios Antoniadis Dimitrios Chountis Ioannis Mantas Ioannis Lekakis Moses Elisaf Charalampos Karvounis Athanasios Manolis Georgios Hahalis Ioannis Kogias Theodora Tourtoglou Dimitrios Gourlis Dimitrios Tsounis TIGREECE Study Inves Source Type: research
The Versatility of Atherosclerotic Cardiovascular Disease Risk Score in Determination of Popliteal Artery Branches Patency in Computed Tomography Angiography
CONCLUSIONS: The 10-year ASCVD risks showed significant higher values in the greater than or equal to 50% stenosis group of popliteal, anterior tibial, and posterior tibial arteries. These findings can establish the further study on how ASCVD risks can be applied to predict the stenosis of these arteries and guide the rationale of preoperative leg CTA for FFF harvest.PMID:36733947 | PMC:PMC9886511 | DOI:10.1097/GOX.0000000000004791
Source: Atherosclerosis - February 3, 2023 Category: Cardiology Authors: Natthapong Kongkunnavat Jirapat Tianrungroj Nutcha Yodrabum Source Type: research
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
CONCLUSION: For primary prevention of CVD in Korean adults with T2DM, it can be helpful to lower LDL-C targets when there are chronic kidney disease, HT, a long duration of diabetes mellitus, or three or more CV risk factors.PMID:36727163 | DOI:10.4093/dmj.2021.0344
Source: Atherosclerosis - February 2, 2023 Category: Cardiology Authors: Min Kyong Moon Junghyun Noh Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research
Association of hyperuricemia with cardiovascular diseases: current evidence
Hosp Pract (1995). 2023 Feb 2. doi: 10.1080/21548331.2023.2173413. Online ahead of print.ABSTRACTThe aim of the present study is to present a historical and unified perspective on the association of serum uric acid (SUA) in the cause cardiovascular diseases (CVDs). The association of hyperuricemia (HUC) with CVD begun to be appreciated in the middle 1950s and early 1990s when clinical evidence was shown on the association of HUC with CVD. However, this association was disputed by several investigators including the Framingham group and by professional societies, like the American Heart Association and the American Society ...
Source: Atherosclerosis - February 2, 2023 Category: Cardiology Authors: Steven G Chrysant Source Type: research
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
CONCLUSION: For primary prevention of CVD in Korean adults with T2DM, it can be helpful to lower LDL-C targets when there are chronic kidney disease, HT, a long duration of diabetes mellitus, or three or more CV risk factors.PMID:36727163 | DOI:10.4093/dmj.2021.0344
Source: Atherosclerosis - February 2, 2023 Category: Cardiology Authors: Min Kyong Moon Junghyun Noh Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research
The role of miRNAs in insulin resistance and diabetic macrovascular complications - A review
Int J Biol Macromol. 2023 Jan 6:123189. doi: 10.1016/j.ijbiomac.2023.123189. Online ahead of print.ABSTRACTDiabetes is the most prevalent metabolic disturbance disease and has been regarded globally as one of the principal causes of mortality. Diabetes is accompanied by several macrovascular complications, including stroke, coronary artery disease (CAD), and cardiomyopathy as a consequence of atherosclerosis. The onset of type 2 diabetes is closely related to insulin resistance (IR). miRNAs have been linked to various metabolic processes, including glucose homeostasis, regulation of lipid metabolism, gluconeogenesis, adipo...
Source: Atherosclerosis - January 9, 2023 Category: Cardiology Authors: Sherif S Abdel Mageed Ahmed S Doghish Ahmed Ismail Ahmed A El-Husseiny Sylvia F Fawzi Abdulla M A Mahmoud Hesham A El-Mahdy Source Type: research
REACHing conclusions on the external applicability of the THEMIS into clinical practice
The THEMIS Study (Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients) was a phase 3 randomized, double-blinded, placebo-controlled trial from 2014 to 2016. Patients with angiographically proven coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM), but no prior history of myocardial infarction (MI) or stroke, were randomized 1:1 to either ticagrelor or placebo in addition to low-dose aspirin for a median follow-up of 39.9 months. The randomized population (n = 19,220) had a median age of 66years, 31.4% were women, and there was a high prevalence of concomitant hypertension, dyslipidemi...
Source: International Journal of Cardiology - December 31, 2022 Category: Cardiology Authors: Rahul Gupta, Adriana C. Mares Tags: Editorial Source Type: research
High Mean Platelet Volume Is Associated with Cerebral White Matter Hyperintensities in Non-Stroke Individuals
CONCLUSION: We found that high MPV level is independently associated with cerebral WMH. This result suggests that platelet activation plays a role in the development of cerebral WMH.PMID:36579377 | DOI:10.3349/ymj.2022.0368
Source: Atherosclerosis - December 29, 2022 Category: Cardiology Authors: Jung-Won Choi Kee Ook Lee Ye-Ji Jang Hyun-Kyung Kim Taeho Seo Yoo Jeong Roh Seung-Ook Choo Seung-Hun Oh Source Type: research
Effects of the Sodium-Glucose Cotransporter Inhibitors on Cardiovascular Death and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Clinical Trials
ConclusionsSodium-glucose cotransporter inhibitors significantly reduced major adverse cardiovascular events, including hospitalization and all-cause mortality in patients with or without established atherosclerotic cardiovascular disease. We observed a beneficial trend in patients with heart failure with preserved ejection fraction, and no benefi ts in patients with stroke or myocardial infarction.
Source: American Journal of Cardiovascular Drugs - December 27, 2022 Category: Cardiology Source Type: research
